Shannon L Stott

Plain English
This research studied how the stiffness of the surfaces where pancreatic cancer cells grow affects the amount and type of tiny bubbles called extracellular vesicles (EVs) that the cells release. It found that cells on softer surfaces produced over 40 times more EVs than those on stiffer surfaces and that these EVs contained more RNA related to important cellular functions. Understanding how the environment impacts EV production is important because it can help improve strategies for diagnosing and treating pancreatic cancer. Who this helps: This helps patients with pancreatic cancer by improving diagnostic tools and treatment options.

Plain English
This study looked at how chemotherapy affects tiny particles called extracellular vesicles (EVs) in the testis of young boys. The researchers found that when Sertoli cells (support cells in the testis) were exposed to the chemotherapy drug cisplatin, they released more EVs that could trigger cell death in themselves but protect germ cells (which develop into sperm) from damage. This research is important because it suggests that understanding and manipulating these EVs could help protect the fertility of boys undergoing cancer treatment. Who this helps: This helps young male cancer patients at risk of losing their fertility due to chemotherapy.

Plain English
This study focused on how changes in the FGFR2 gene affect the structure of bile ducts in the liver, specifically in a type of cancer called intrahepatic cholangiocarcinoma. The researchers used a special 3D model to show that these FGFR2 changes not only disrupt the normal formation of bile ducts but do so in different ways depending on the state of the cells involved. For instance, specific FGFR2 mutations led to significant alterations in bile duct structure, which could help understand how this cancer develops and progress. Who this helps: This helps patients with intrahepatic cholangiocarcinoma and their doctors by providing insights into the disease's biology.

Plain English
This study developed a new device to detect the SARS-CoV-2 virus in bodily fluids like blood, saliva, and stool. The device can identify very low amounts of the virus, detecting as few as 3 viral particles per milliliter, and was able to find the virus in 72% of blood samples taken from patients with COVID-19. This is important because it offers a highly sensitive way to monitor viral infections, which can help in managing COVID-19 and potentially other viral diseases. Who this helps: This helps patients and doctors by improving the ability to diagnose and track viral infections.

Plain English
This study looked at how advanced materials and machine learning can help doctors analyze cancer cells and tiny particles called extracellular vesicles that are released by tumors. Researchers found that these methods can better identify the different types of tumor cells circulating in the body, which is important because over 95% of cancer deaths are linked to tumor metastasis. By improving our understanding of these tumor markers, we can develop more effective cancer treatments tailored to individual patients. Who this helps: This research benefits cancer patients by providing new ways to diagnose and treat their disease more effectively.

Plain English
This study examined how certain structures in the tumor called tertiary lymphoid structures (TLS) can help predict which patients with head and neck cancer will respond to a specific type of immunotherapy known as immune checkpoint blockade (ICB). Researchers looked at tumor samples from 20 patients, finding that those who responded to treatment had more B cells present and better survival rates when TLS were located close to the tumor. The study also showed that measuring TLS density could predict treatment response with 80% accuracy, suggesting it may be a better indicator than the currently used marker. Who this helps: This helps patients with recurrent head and neck cancer by improving treatment prediction and outcomes.

Plain English
This study focused on improving how we detect and analyze tiny particles called extracellular vesicles and circulating tumor cells from blood samples of brain cancer patients. Researchers created a new method that significantly boosts the signal from these particles, making them easier to see—over six times stronger than traditional methods. This improvement is important because it allows for a better understanding of cancer and could lead to more precise diagnostics and treatments. Who this helps: This helps patients with brain cancer and doctors working to diagnose and treat them.

Plain English
Researchers studied how changes in blood samples containing tumor DNA could help predict how well patients with advanced head and neck cancer respond to treatment and how long they might live. They found that when patients had lower levels of this tumor DNA during treatment, they were more likely to respond positively and have better survival rates. This is important because using this DNA information could help doctors make better treatment decisions, potentially improving outcomes for patients.

Plain English
Researchers studied patients with a severe type of head and neck cancer that often comes back or spreads. They found that monitoring a specific marker in the blood, known as circulating tumor DNA (ctDNA), can help predict how well patients will respond to treatment and how long they might live. This is important because it offers a new way to tailor treatments to individual patients, potentially improving their chances of survival and minimizing side effects from ineffective therapies.

Plain English
This study focused on a specific type of tiny particles released by blood vessel cells, called VCAM-1 endothelial cell-derived extracellular vesicles (EC-EVs), which are important in cardiovascular disease. Researchers developed a new method using a special chip to isolate these vesicles more effectively and found that the method could capture significantly more of them (with specific increases noted at less than 0.001 in various measurements) than previous techniques. This matters because being able to study these vesicles could lead to better understanding and monitoring of heart-related conditions and possibly inform new treatments. Who this helps: Patients with cardiovascular diseases and their doctors.

Plain English
This study looked at how combining a drug that stimulates the immune system (TLR8 agonist) with another drug that blocks a tumor's defenses (PD-1 blockade) works in patients with head and neck cancer. Researchers found that patients who received both treatments showed a significant increase in immune system activity, including more immune cells that attack tumors. This is important because it suggests that this combination could make cancer treatments more effective. Who this helps: Patients with head and neck cancer.

Plain English
This study looked at how certain immune cells in head and neck cancer tumors can predict whether patients will respond well to a treatment called immune checkpoint blockade (ICB). The researchers found that patients who responded to ICB had a higher amount of B lymphocytes (CD20+ cells) in their tumors compared to those who did not respond (22% vs. lower levels). Additionally, certain structures called Tertiary Lymphoid Structures (TLS) near the tumors were linked to better survival rates, with a 4% higher chance of overall survival among patients with these structures. Who this helps: This research helps patients with head and neck cancer by identifying better predictors of treatment response.

Plain English
This study looked at how two methods of cancer treatment—using a TLR8 agonist along with PD-1 blockade—work together in patients with head and neck cancer. The researchers examined tumor samples before and after treatment and found that patients who received both therapies showed significant increases in immune system activity, including more dendritic cells that help fight tumors and higher densities of cytotoxic T-cells, indicating a stronger immune response. This matters because understanding how these treatments enhance the immune response can lead to better cancer therapies. Who this helps: This research benefits cancer patients, especially those with head and neck squamous cell carcinoma.

Plain English
This research paper examines the potential of tiny particles called extracellular vesicles (EVs) in treating diseases related to the heart, lungs, blood, and sleep. The study found that while these EVs could be effective therapies, current methods for producing them at a clinical level face significant challenges, such as understanding their production and ensuring their quality. The findings highlight the need for better techniques in manufacturing and testing EVs to make them suitable for medical use. Who this helps: This research benefits patients with heart, lung, blood, and sleep diseases by improving potential treatments.

Plain English
This study focused on schwannomas, tumors that arise mostly from a specific genetic mutation linked to neurofibromatosis type 2 (NF2). Researchers discovered that a protein called merlin, which is missing in these tumors, causes cells to behave unpredictably, leading to different types of tumor characteristics. This finding is important because understanding how variability develops in these tumors can help scientists develop better treatment strategies. Who this helps: This helps patients with schwannomas and doctors treating them.

Plain English
This study focused on how cancer cells adapt when they don't have enough glutamine, a nutrient they need to grow. The researchers discovered that cancer cells can lower the activity of an enzyme called P5CS to help them make their own glutamine when it's scarce. This ability to change their metabolism is important because it suggests new ways to treat cancer by targeting this process. Who this helps: This information benefits doctors and researchers looking for new cancer treatments.

Plain English
This study explored a new way to improve plastic microfluidic devices, which are used to isolate cells and proteins, by attaching a chemical called biotin to their surfaces. The researchers found that their method using aryl-diazonium salts made the process faster, safer, and cheaper, resulting in more efficient capture of target substances. This approach can significantly boost the production and effectiveness of diagnostic tests. Who this helps: Patients and healthcare providers using diagnostic tests.

Plain English
The AMBUSH trial is designed to study how well a specific treatment works for older patients (18 and up) with medulloblastoma (a type of brain cancer) or pineal embryonal tumors. Researchers found that about 60% of these patients have changes in a gene pathway that could be targeted by new treatments, and over 80% of those patients might benefit from a specific drug that blocks this pathway. This matters because it provides a potential new option for a group of patients that currently has very few tailored treatments available. Who this helps: This helps patients with medulloblastoma, particularly adults and young adults who are often underrepresented in treatment studies.

Plain English
This study looked at a specific type of RNA called human satellite II (HSATII) in patients with epithelial ovarian cancer. Researchers found that high levels of HSATII were linked to a more aggressive cancer behavior and shorter survival rates; patients with elevated HSATII had significantly worse outcomes compared to those with lower levels. By targeting HSATII, there may be new ways to enhance the immune response against cancer. Who this helps: This benefits patients with ovarian cancer by providing potential new treatment strategies.

Plain English
Researchers studied a new way to preserve rat livers for longer periods of time by partially freezing them at very low temperatures (-10 to -15°C). This method allowed for a preservation time that was five times longer than the previous best methods. Although the frozen livers had some differences in quality, this breakthrough can significantly help address the shortage of organs for transplantation. Who this helps: This benefits patients in need of liver transplants.

Plain English
This study looked at how different parts of prostate tumors respond to cancer treatments, particularly focusing on protein activity within tumor cells. Researchers found that bone metastases showed higher signaling activity related to cancer growth compared to other areas, like the lungs and liver, and blocking a specific protein called c-MET slowed tumor growth in the bones. This understanding of tumor behavior helps in tailoring treatments more effectively, especially since more active tumor cells are sensitive to certain drugs, while less active ones might become resistant over time. Who this helps: Patients with metastatic prostate cancer will benefit from these insights for better-targeted therapies.

Plain English
This research studied how certain cancer cells, called circulating tumor cells (CTCs), survive in the bloodstream of melanoma patients and develop resistance to treatments. The researchers found that these cells use a regulator called SREBP2 to increase levels of a protein called transferrin, which helps manage iron in the cells, ultimately making them more resilient to both treatment and stressors that typically kill cancer cells. Specifically, patients whose CTCs showed high activity in these pathways had worse outcomes, regardless of the treatment they were receiving. Who this helps: This information benefits melanoma patients by highlighting potential targets for new treatments.

Plain English
This study looked at how freezing plasma samples at very low temperatures affects the storage of tiny particles called extracellular vesicles (EVs) and their RNA content, which can be useful for medical tests. Researchers found that after storing these samples for up to 12 days, the number of EVs dropped to just 23% of what was found in fresh samples, and the RNA yield from the stored samples was only 47-58% compared to fresh ones. This matters because it highlights the need for better preservation methods to maintain the quality of biological samples for future diagnostics. Who this helps: This helps researchers and healthcare providers who need reliable biological samples for testing and diagnostics.

Plain English
This study looked at how tumor cells influence immune cells called macrophages in triple-negative breast cancer (TNBC). Researchers found that tumor-derived particles (extracellular vesicles) change macrophages in a way that promotes cancer spread, increasing the likelihood of metastasis to the lungs when these educated macrophages were injected alongside tumor cells into mice. Specifically, they discovered that a protein called CCL5 plays a crucial role in this process by controlling how tumor cells interact with macrophages. Who this helps: This helps patients with triple-negative breast cancer by identifying potential targets for treatment that could prevent cancer spread.

Plain English
This study focused on improving the detection of circulating tumor cell clusters (CTCCs) in blood, which are known to be much more dangerous than single tumor cells. The researchers created a special device that can efficiently separate these clusters from large amounts of blood—up to 30 milliliters per hour—with an impressive 80% success rate while keeping nearly all other blood cells out of the sample. This advancement is important because it allows for better diagnosis and treatment planning for cancer patients by providing more accurate tumor information from blood samples. Who this helps: This helps cancer patients by providing more precise diagnostic tools.

Plain English
This study looked at how liver cells are released from rat livers during a process called cold ischemia and machine perfusion. Researchers found that specific liver cells, like hepatocytes and immune cells, were present in the blood used to keep the livers alive outside the body, and the types and amounts of these cells changed based on how long the liver had been cold. This research helps identify potential markers to assess the health of liver organs for transplant, which is important given the shortage of available donor organs. Who this helps: This helps patients needing liver transplants and the doctors who care for them.

Plain English
This study looked at a new device called the CTC-iChip, which can sort through a large volume of blood to identify cancer cells, specifically circulating tumor cells (CTCs). The researchers found that this method can recover 86% of CTCs while processing over 6 billion cells at once, which is 100 times more effective than previous techniques. This improvement is important because it allows doctors to detect cancer cells more easily and accurately, which can help with diagnosis and treatment monitoring. Who this helps: This benefits patients with cancer by improving the ability to detect and monitor their disease.

Plain English
Researchers developed a new technique that allows them to study specific types of cells within a mixed sample without needing to separate those cells first. This method improves upon traditional approaches by using special reagents to perform genetic analysis on individual cells directly, which enhances the ability to identify rare cell types that are often overlooked. The new method simplifies the process of studying diverse cell populations and could be valuable in areas like drug development and biological research. Who this helps: This helps researchers and doctors who are looking to better understand diseases at the cellular level.

Plain English
This study looked at how biomolecules, cryoprotectants (which help preserve biological materials), and water behave at a molecular level when preserved under low temperatures and dryness. It found that understanding the interactions between these elements is essential for improving preservation methods, potentially leading to the development of better cryoprotectants. This matters because it can enhance the survival of biological materials, which is important for medical and scientific applications. Who this helps: This helps patients and researchers working with preserved biological samples.

Plain English
This study examined how poly(vinyl alcohol) (PVA) can help prevent ice from forming larger crystals, a process called ice recrystallization. Researchers found that PVA molecules work effectively by fitting well with the water molecules in ice, which helps stop big ice crystals from forming. They discovered that the length of the PVA molecule is important; longer molecules with more connection points (hydroxyl groups) are better at this job. Understanding how PVA interacts with ice could lead to better synthetic anti-ice materials, which is important for various industries. Who this helps: This helps patients who use cryopreservation for medical treatments and the scientists and doctors developing these technologies.

Plain English
This study looked at how analyzing certain blood markers, specifically circulating tumor cells (CTCs), can help predict the treatment response and disease spread in prostate cancer patients. It found that higher levels of a CTC score in patients with advanced prostate cancer indicated a much greater risk of shorter survival—6 times worse overall survival and over 3 times shorter time before the cancer worsened. In patients with early-stage prostate cancer, a higher CTC score also predicted the spread of cancer to nearby areas with high accuracy. Who this helps: This research benefits prostate cancer patients by providing important information for tailoring their treatments.

Plain English
This study developed a new tool, called the HB-Chip, that can quickly and accurately isolate specific tiny particles (extracellular vesicles) from tumors. The HB-Chip achieved a remarkable 94% accuracy in identifying these tumor-derived particles and could detect as few as 100 of them in a sample, making it much more effective than previous methods. This is important because it allows for better diagnosis and understanding of brain cancer, specifically glioblastoma, by revealing genetic information that could guide treatment. Who this helps: This benefits patients with glioblastoma and doctors treating them.

Plain English
This study looked at a new way to freeze and preserve rare cancer cells found in the blood of patients. Researchers developed a faster cooling technique to keep these fragile cells alive, and found that after being thawed, the cells remained healthy and could grow in the lab. Specifically, five different cell lines were preserved successfully, and tests showed that their important markers and genetic material were intact. Who this helps: This benefits cancer patients and researchers by providing a reliable method to store and study tumor cells without needing immediate testing.

Plain English
This research looked at using blood tests, called "liquid biopsies," to help diagnose and track gliomas, particularly the aggressive type known as glioblastoma. The study found that these blood-based markers, such as circulating tumor cells and DNA, could provide valuable information about the tumor's characteristics and response to treatment without needing invasive procedures. This matters because it can improve how doctors monitor the disease and adapt treatments more effectively, especially as targeted therapies become more common. Who this helps: Patients with gliomas and their doctors.

Plain English
This study looked at how different conditions affect blood clotting in tiny devices used for medical testing. The researchers found that when fresh blood flows quickly through these devices, it only clots under high pressure, and a drug called tirofiban is very effective at preventing clots. However, stored blood clots more easily, and they suggest using both tirofiban and other antioxidants to stop this from happening. This research is important because it helps improve the reliability of blood testing and treatment devices. Who this helps: This benefits patients and doctors by enhancing blood processing in medical devices.

Plain English
This study focused on updating guidelines for researching extracellular vesicles (EVs), which are tiny structures released by cells and can carry important information. The International Society for Extracellular Vesicles updated their rules from 2014 to help scientists provide clearer information about how these vesicles function and how to study them properly. They emphasized the need to report specific details to ensure research on EVs is accurate and reliable. Who this helps: This benefits researchers and scientists studying cell communication and disease mechanisms.

Plain English
Researchers studied how well cells from blood vessel linings, called endothelial cells, could survive and attach in a model at very low temperatures, especially when ice formed around them. They found that at -6 degrees Celsius, cells were better at attaching when ice was created by certain bacteria, but below this temperature, they needed extra help from a special sugar called 3-methyl-D-glucose and a plastic substance called polyethylene glycol to stay intact. This is important because it helps improve the process of preserving cells and tissues for medical uses like transplants. Who this helps: This helps patients needing organ transplants and doctors involved in tissue preservation.

Plain English
This study focused on improving the process of locating and retrieving rare tumor cells found in the blood of breast cancer patients. Researchers developed a new method using a small device that captures these cells, allowing them to be easily removed while keeping them alive for further analysis. As a result, their technique captured more cells—showing better efficiency than previous methods—and made it easier to study the specific genes linked to breast cancer. Who this helps: This benefits breast cancer patients and their doctors by providing better tools for monitoring and understanding their condition.

Plain English
This study looked at how to control ice formation using freeze-dried bacteria (Pseudomonas syringae) wrapped in small alginate beads. The researchers found that the amount of bacteria in the beads was key to effective ice formation, with larger amounts leading to higher freezing temperatures. This discovery can help improve processes in food preservation and medicine by allowing more consistent and controlled ice formation. Who this helps: This benefits food scientists, medical researchers, and anyone involved in cryotechnology.

Plain English
This study focused on developing a new device to isolate clusters of circulating tumor cells (CTC clusters) from blood, which could be crucial for understanding cancer spread. The new microfluidic chip successfully recovered 99% of large CTC clusters, while keeping 87% of the cells alive and significantly reducing unwanted red blood cells. This matters because being able to isolate intact CTC clusters can improve cancer diagnosis and treatment monitoring. Who this helps: Patients with cancer and their doctors.

Plain English
Researchers developed a special preservative solution designed to keep red and white blood cells healthy during storage without refrigeration. Their study found that after 72 hours at room temperature, blood treated with this solution had better-looking red blood cells and white blood cells that were more alive and functional compared to untreated blood. This is important because it can improve how blood samples are transported and used in research and clinical settings, making them more reliable. Who this helps: This benefits patients, doctors, and researchers who work with blood samples.

Plain English
This study looked at how using liquid biopsies—samples taken from blood or cerebrospinal fluid—can help diagnose and monitor brain tumors like glioblastoma. The research found that analyzing circulating tumor cells and other genetic materials could significantly improve the way these tumors are tracked during treatment. This matters because it could lead to more accurate and less invasive testing, making it easier to personalize treatment plans for patients. Who this helps: This benefits patients with brain tumors and their doctors.

Plain English
Researchers studied a new device called the CTC-iChip, designed to quickly filter out blood cells to isolate rare circulating tumor cells (CTCs) from cancer patients. This chip can process blood samples at an impressive rate of 15-20 million cells per second and successfully purifies CTCs while removing red blood cells and white blood cells. Analyzing over 2,500 CTCs from 38 patients with various cancers showed varied characteristics among the cells, which is important for understanding cancer progression and developing personalized treatments. Who this helps: This benefits cancer patients by improving blood tests that guide their treatment options.

Plain English
This study looked at a new method to isolate cancer cells that are covered by platelets, which helps them hide from the immune system. The researchers found they could successfully isolate these "stealth" cancer cells from 66% of lung cancer samples, 60% of breast cancer samples, and 83% of melanoma samples. This method is important because it may reveal hidden aspects of how cancer spreads and interacts with the body. Who this helps: This benefits patients with cancer by potentially improving diagnosis and treatment strategies.

Plain English
This study focused on developing a new type of device that can trap and observe single cells to measure how easily their membranes allow substances to pass through. The researchers created a simple microarray that could capture up to 86.8% of individual cells and found that rat liver cells were highly permeable to water and small molecules, while a type of cancer cell (Brx-142) showed lower permeability and different transport behavior. These findings are important because they enhance our understanding of how cells interact with their environment, which is crucial for improving treatments and preserving rare cells. Who this helps: This helps researchers and doctors working with cancer patients and cell preservation.

Plain English
This study focused on finding a way to keep whole blood stable for up to 72 hours so that rare cancer cells called circulating tumor cells (CTCs) could be isolated and studied without losing their quality. The researchers found that their method preserved the cancer cells well, allowing for accurate detection of specific cancer markers in prostate cancer patients, with a success rate of 92% when comparing fresh and preserved samples. This is important because it means doctors can use blood samples collected earlier for testing cancer, making the process more convenient and reliable. Who this helps: This helps patients needing cancer diagnosis and monitoring.

Plain English
This research paper examines circulating tumor cell clusters, which play a key role in the spread of cancer throughout the body. The study found that new technologies can help isolate these clusters from a patient's blood, which is crucial because these clusters are highly capable of causing metastasis. Understanding and targeting these clusters can improve cancer diagnosis and treatment, potentially leading to better outcomes for patients. Who this helps: This helps cancer patients and their doctors.

Plain English
This study explored a new method for sorting cells based on their physical properties, specifically how easily they deform as they move through a small channel. Researchers found that by measuring how long it takes for cells to pass through this channel, they could identify and separate tumor cells from blood samples, including those from prostate cancer patients. This method not only sorts the cells but also allows for further analysis of their molecular characteristics, which can enhance our understanding of cancer. Who this helps: This helps patients and doctors by improving the ability to detect and analyze cancer cells in blood samples.

Plain English
This study looked at how groups of cancer cells in the bloodstream, known as circulating tumor cell (CTC) clusters, can travel through tiny blood vessels, which was previously thought to be impossible. The researchers found that more than 90% of these clusters, made up of up to 20 cells, could pass through narrow vessels in lab tests and even in actual blood. This is important because it shows that these clusters can more easily spread cancer to other organs than we thought, highlighting potential new ways to stop this process. Who this helps: This helps patients by providing insights into more effective cancer treatments.

Plain English
This study examined how ice forms in tiny droplets made of different mixtures of heavy water (D2O) and regular water (H2O), both with and without ice-nucleating bacteria called Pseudomonas syringae. The researchers found that a solution with 1 mg/mL of these bacteria froze at -4.6°C when using 100% D2O, compared to -8.9°C for 100% H2O. Understanding how to control ice formation is important because it can improve methods for preserving biological samples at low temperatures. Who this helps: This benefits patients undergoing cryopreservation treatments and the doctors who perform these procedures.